Skip to main content

Vaccine refusal and hesitancy in Spain: an online cross-sectional questionnaire

Abstract

Background

Vaccine refusal and hesitancy represent a crucial challenge to public health, causing delays in vaccination and compromising herd immunity.

Methods

To address this issue, we conducted a comprehensive observational study on the adult Spanish population in 2021. Using an online questionnaire, we examined the sociodemographic and sociocultural factors, beliefs, and opinions of those refusing or hesitant about vaccines, as well as their vaccination behaviors by vaccine type and sex.

Results

There were 1,312 respondents: 74.5% were female, 73.7% were between 31 and 59 years old, and 71.0% had university studies. Our findings revealed that vaccine refusal rates were relatively low (16.8%), and mainly associated with influenza vaccination (10.3%). Higher refusal rates were observed in those over 60 years old, those expressing hesitancy due to vaccine components, those opposing free and compulsory vaccination, those unaware that vaccination protects the community, and those against consuming cow’s milk and using infant formulas for breastfeeding. Vaccine hesitancy was greatest in individuals under 31 years old, women, parents of children under 15 years old, against compulsory vaccination, unaware that vaccination protects the community, with hesitancy due to vaccine costs, and in favour of alternative and complementary treatments.

Conclusions

These insights highlight the need for strategies to improve education about vaccination and dispel misconceptions, which are crucial for effectively reducing vaccine refusal and hesitancy across the population.

Peer Review reports

Background

Vaccination is a cost-effective public health measure that can prevent the spread of diseases and reduce the morbidity burden [1]. High vaccine uptake leads to a decline in the prevalence of vaccine-preventable diseases (VPDs) [2]. Vaccines are safe and effective and, although like medication they can cause adverse effects, these adverse effects are outweighed by individual and collective benefits [1, 3].

The Strategic Advisory Group of Experts (SAGE) Working Group on Vaccine Hesitancy, concluded that vaccination hesitancy refers to delay or refusal of vaccination despite the availability of vaccination services. Vaccine hesitancy is complex and context specific, varying across time, place and vaccines. It is influenced by factors such as complacency, convenience and confidence [4]. Declines in vaccination present threats to herd immunity [5].

According to the World Health Organization (WHO), 1.5 million child deaths from VPDs occur every year worldwide This is partly due to problems of access to vaccines for socio-economic reasons, and partly to vaccination hesitancy generated by the rise of anti-vaccine movements [6, 7]. Vaccination hesitancy is considered a priority line of action for the WHO and a challenge for those countries working to close the immunisation gap [8, 9].

The SAGE Group noted that the Vaccine Hesitancy Determinants Matrix displays the factors influencing the behavioural decision to accept, delay or reject some or all vaccines under three categories: contextual, individual and group, and vaccine/vaccination-specific influences [4]. A publication analysing the psychological factors that might motivate people in 25 countries to refuse vaccination showed that the best predictors of refusal were the following: high levels of conspiracy beliefs, low tolerance of perceived infringement of personal freedom, aversion to needles or blood, and religious beliefs [10]. Another review highlighted the complexity of factors related to acceptance or refusal of vaccines including demographic factors (ethnicity, age, sex, pregnancy, education, and employment), accessibility and cost of vaccines, personal responsibility and risk perceptions, trust in healthcare authorities and vaccines, safety and efficacy of new vaccines, and lack of information or misinformation [11].

In Spain, vaccination coverage is high but varies depending on the vaccine. Vaccination is offered by the national public health system, and most vaccines are provided free of charge and administered primarily in primary care settings, with minor differences between autonomous communities. Data published by the Spanish Ministry of Health in 2022 showed a slight increase from the previous year in primary vaccination coverage (Polio, DTaP, Hib, Hepatitis B, Meningococcus C, Pneumococcus), as evidenced by the percentage of the population receiving the second dose of the hexavalent vaccine (DTaP, Hib, Hepatitis B) increasing from 96.8% in 2021 to 97.6% in 2022. However, coverage of two doses of the Measles, Mumps, and Rubella (MMR) vaccine in 2022 was 92.6% which did not meet the target coverage of ≥ 95% needed to keep measles’ elimination status, even if coverage was achieved considering only one dose. After the positive effect of the COVID-19 pandemic on influenza vaccine coverage, there was a decreasing trend in influenza vaccine coverage in all population groups, while remaining higher than pre-pandemic levels [12].

Vaccine hesitancy had been previously studied in Spain in specific groups such as healthcare professionals (HCPs) and epidemiologists, so we consider it interesting to study it in the general population [13, 14]. Our study aimed to characterise the profile of the Spanish population with vaccination refusal specifically and hesitancy in general, to inform and support the development of educational and communication strategies aimed at improving vaccination coverage. With this objective, we used an online questionnaire to describe the socio-demographic and sociocultural characteristics, beliefs and opinions of those refusing to have vaccine and those with hesitancy about vaccination, and their vaccination behaviours by vaccine type and sex.

Methods

Study design

We conducted an observational, cross-sectional study on individuals accessing an online survey from March to December 2021. The inclusion criteria required participants to be aged 18 years or older and to have the authority to make vaccination decisions for themselves or others in Spain.

We obtained the information through an online, self-administered questionnaire designed by the project research team. A pilot test was performed before the definitive questionnaire was obtained. To ensure the rigor and validity of the study, an experienced research team with expertise in conducting surveys was involved, thereby guaranteeing the quality and reliability of the instrument. Both were registered on a Research Electronic Data Capture (REDCap) web platform stored on a centralized server where the data remain securely in the custody of the Institut Català de la Salut [Catalan Institute of Health]. Anonymous information was exported to the statistical packages used for later analysis. The REDCap platform generated a link [15] for participation in the survey that was disseminated through scientific societies, social networks, research institutes, paediatricians, and nurses in primary care. (Supplementary Material S1)

Variables

The main variables of the questionnaire were: sociodemographic factors (sex, age, having children under 15 years old, level of education); sociocultural factors ( religious beliefs, culture, family); vaccine information variables (whether they have refused any vaccines and, in that case, the type of vaccine refused; who the refused vaccine was for; hesitancy due to vaccine components, associated diseases or to the payment of vaccines; whether they know that personal vaccination protects other people whether they would be in favour of free and compulsory vaccination; opinion about vaccines), variables of trust in the health system (sources of information about vaccines, whether HCPs can understand anti-vaccine arguments, whether HCPs have enough information to satisfy anti-vaccine people, whether when in doubt about vaccines they will consult the HCP); habits (type of diet, consumption of cow’s milk, opinion on breastfeeding or artificial breastfeeding, opinion on alternative treatments or complementary treatments).

Statistical analysis

The data were gathered in an anonymized database using the REDCap platform. We conducted a descriptive analysis of the findings, categorizing qualitative or ordinal data using absolute and relative frequencies. In the statistical analysis, only complete cases were considered, and missing values were assumed to be missing at random. We evaluated the relative frequency of the categorical variables using the Chi square test or Fisher’s exact test and identified the variables that were both statistically significant and clinically relevant. In selected subgroups of interest, we identified the factors independently associated with these results. The relationship between the variables is quantified using Odds Ratios (ORs), with 95% confidence interval (CI) estimates, as a measure of association for risk. We used logistic regression to identify which factors are independently linked to vaccination refusal or to hesitancy due to vaccine components or diseases that have been associated to being vaccinated. We employed a stepwise conditional variable recall model that retains variables at an adjusted p-value of < 0.05 and excludes variables with a value > 0.10. This included factors that were statistically significant in our initial comparisons of two variables at a time. We report the likelihood of these factors as ORs and their statistical significance (as adjusted p-values), using a cut-off of p < 0.05 to define statistical significance. All analysis was conducted using SPSS software version 26.0.

Ethical considerations

This study was approved by the ethics and clinical Research Committee of the Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), with code 20/221-P. The study was conducted following the principles of the Declaration of Helsinki. The variables collected were treated anonymously to guarantee the confidentiality of the data, as established in Regulation (EU) 2016/679 of the European Parliament and the Council of April 27 on Data Protection (RGPD) and the Spanish Organic Law 3/2018, of the 5th December 2018, regarding the protection of personal data and guarantees of digital rights. The database is kept by the principal investigator and the research team in an Excel format, protected by password access. An anonymized database was used for the analysis. Before conducting the survey, online informed consent was completed, accepted, and signed.

Results

Description of the study population and percentages of vaccine refusal and hesitancy (Table 1)

Table 1 Description of the study population

A total of 1,312 individuals participated in the survey, of whom 74.5% were female and 25.5% male. Regarding age distribution, 14.0% were under 31 years old, 73.7% were between 31 and 59, and 12.4% were over 59. University education was reported by 71.0% of respondents.

Among all respondents, 1,294 answered the question on vaccine refusal, with 16.8% (218/1,294) reporting having refused at least one vaccine. The most frequently refused vaccines were influenza (61.9%), followed by tetanus (18.3%) and HPV (16.1%). Additionally, among vaccines not funded by the Spanish Health System in 2019, 11.0% of respondents refused the rotavirus vaccine, 8.3% refused meningococcus B, and 6.9% refused meningococcus ACWY.

Regarding the number of vaccines refused, 66% of respondents who had refused vaccines rejected only one, while 34% refused two or more. In terms of for whom vaccines were refused, the majority (73.4%) had refused vaccines for themselves, while 34.4% refused them for their children and 3.7% for their parents or others.

Vaccine hesitancy was primarily linked to concerns about vaccine components (28.1%), perceived associations with diseases (30.9%), and vaccine costs (29.0%). Overall, 76.1% of respondents expressed strong support for vaccines, while a small proportion were neutral or expressed slight (3.4%) or strong (1.3%) disagreement.

Socio-demographic and Sociocultural characteristics, beliefs, and opinions of the population who refused vaccines

Vaccine refusal was associated with older age (≥ 60 years) (OR = 2.11, 95% CI: 1.22–3.72, p = 0.008), a cultural and familial background against vaccination (OR = 4.74, 95% CI: 2.26–9.74, p < 0.001), and hesitancy due to vaccine components (OR = 0.39, 95% CI: 0.29–0.52, p < 0.001) or vaccine-associated diseases (OR = 0.45, 95% CI: 0.33–0.60, p < 0.001). Vaccine refusers were also less aware of community-wide benefits (OR = 4.52, 95% CI: 2.48–8.16, p < 0.001) and more likely to oppose free and compulsory vaccination (OR = 4.60, 95% CI: 3.39–6.26, p < 0.001) (Tables A1 and A2).

Additionally, vaccine refusers showed lower trust in HCPs and healthcare websites as sources of vaccine information, relying more on friends. They perceived HCPs as uninformed on vaccine hesitancy (OR = 1.74, 95% CI: 1.29–2.34, p < 0.001) and were unlikely to consult them for vaccine-related concerns (OR = 4.46, 95% CI: 2.71–7.29, p < 0.001) (Table A2). Lifestyle factors, such as opposition to cow’s milk consumption (OR = 3.41, 95% CI: 1.79–6.30, p < 0.001), using infant formula instead of breastfeeding (OR = 6.16, 95% CI: 3.02–12.5, p < 0.001), and support for alternative medicine, were also linked to increased vaccine refusal (Table A2).

The multivariate logistic regression analysis (Table 2) confirmed that individuals aged 60 years or older, those hesitant due to concerns about vaccine components (OR: 1.676; p = 0.003), those opposed to free and compulsory vaccination (OR: 0.278; p < 0.000), those unaware that vaccines protect the community, and individuals who opposed consuming cow’s milk and the use of infant formulas were independently associated with vaccine refusal (Table 2).

Table 2 Dependent variable: refusal of vaccination

Socio-demographic and sociocultural characteristics, beliefs and opinions of the population with hesitancy due to vaccine components, associated diseases, or payment

Women (OR: 1.55; 95% CI: 1.15–2.10; p = 0.004), parents with children under 15 years old (OR: 0.74; 95% CI: 0.58–0.95; p = 0.018), and individuals with a cultural background (OR: 7.48; 95% CI: 2.44–28.3; p < 0.001) or family opposed to vaccination (OR: 3.83; 95% CI: 1.88–7.98; p < 0.001) were more likely to express hesitancy due to concerns about vaccine components. Additionally, hesitancy related to vaccine-associated diseases was more frequent in individuals under 30 years old, women, those without a university education (OR: 0.73; 95% CI: 0.57–0.95; p = 0.018), parents of children under 15 years old, and those influenced by a cultural background or family opposed to vaccination (Table A1).

Individuals expressing hesitancy due to vaccine components (Table A3) or vaccine-associated diseases (Table A4) were also more likely to be hesitant about vaccine payment (OR for component-related hesitancy: 0.41; 95% CI: 0.32–0.53; p < 0.001, and OR for disease-related hesitancy: 0.46; 95% CI: 0.36–0.59; p < 0.001). They were less likely to be aware that individual vaccination protects the community (OR for component-related hesitancy: 3.50; 95% CI: 1.95–6.36; p < 0.001, and OR for disease-related hesitancy: 5.25; 95% CI: 2.86–10.1; p < 0.001) and were less supportive of free and compulsory vaccination (OR for component-related hesitancy: 3.11; 95% CI: 2.41–4.02; p < 0.001, and OR for disease-related hesitancy: 2.63; 95% CI: 2.05–3.38; p < 0.001). Their preferred sources of information were social networks, family, and friends, and they exhibited a lower level of trust in HCPs. Many of these individuals considered HCPs as uninformed on vaccine hesitancy and were unlikely to consult them for vaccine-related concerns (OR for component-related hesitancy: 4.39; 95% CI: 2.72–7.20; p < 0.001, and OR for disease-related hesitancy: 3.69; 95% CI: 2.28–6.05; p < 0.001).Hesitancy was also more frequent among respondents who opposed vaccines, the use of infant formula, and the consumption of cow’s milk (OR for component-related hesitancy: 4.26; 95% CI: 2.37–7.64; p < 0.001, and OR for disease-related hesitancy: 3.72; 95% CI: 2.09–6.65; p < 0.001), as well as those who did not follow a Mediterranean diet and favored alternative and complementary treatments (Tables A3 and A4).

Multivariate logistic regression identified significant independent associations between hesitancy due to vaccine components or vaccine-associated diseases and certain demographic and behavioral factors. Specifically, hesitancy was higher among individuals under 30, women (OR: 1.494; p = 0.009), parents of children under 15 (OR: 0.669; p = 0.006), those unaware that vaccination protects the community (OR: 0.418; p = 0.019), those opposed to free and compulsory vaccination (OR: 0.436; p < 0.001), and those hesitant about vaccine payment. Support for alternative (OR: 0.488; p < 0.001) and complementary treatments (OR: 1.549; p = 0.001) was also independently associated with vaccine hesitancy (Table 3).

Table 3 Dependent variable: hesitancy due to vaccine components or associated diseases

Hesitancy due to vaccine payment was more prevalent among individuals younger than 30 years old, those without a university degree, and parents with children under 15 years old (Table A1). Those who opposed free and compulsory vaccination (OR: 1.48; 95% CI: 1.15–1.91; p = 0.003) and considered friends to be reliable sources of vaccine information (OR: 2.65; 95% CI: 1.45–4.86; p = 0.002) were also more likely to exhibit hesitancy related to vaccine cost. Individuals with vaccine payment hesitancy were more likely to report that HCPs were uninformed on vaccine concerns (OR: 1.44; 95% CI: 1.12–1.85; p = 0.004) and demonstrated higher levels of vaccine skepticism and were in favour of alternative treatments (Table A5).

Vaccination behaviours by vaccine type and sex

Individuals aged 60 years or older exhibited a higher refusal rate for influenza and tetanus vaccines. Men were more likely to refuse tetanus vaccines (OR: 0.33; 95% CI: 0.17–0.62; p = 0.001), whereas university students demonstrated greater refusal of rotavirus vaccines. Parents with children under 15 years of age displayed a higher refusal of Haemophilus influenzae type B, Meningococcal B, and Rotavirus vaccines (Table A6).

Women exhibited greater hesitancy regarding the vaccination of their children (OR: 1.97; 95% CI: 1.06-4.00; p = 0.030) and expressed more concerns about vaccine components or related diseases, particularly those without children under 15 years of age. Men were more likely to disagree with vaccines in general and tended to rely more on social networks, television, and radio for vaccine-related information. In contrast, women preferred complementary treatments and considered health websites more reliable sources of vaccine information (Tables A7 and A8).

Discussion

In our study, we found that respondents generally favored vaccination, with a refusal prevalence of 16.8%. This rate aligns with published data on the intention to refuse the COVID-19 vaccine in the Catalan population during the same year as the study. This indicates that the vaccine hesitancy observed in our sample is consistent with broader regional trends. Additionally, within this inquiry, we detected an increase in doubts about vaccines as a result of the pandemic [16], which mirrors global trends of heightened vaccine skepticism fueled by misinformation and rapidly evolving scientific guidelines during the COVID-19 crisis.

Although official data on vaccine rejection are not available to us, we do have official records from the Spanish Ministry of Health outlining vaccine acceptance trends [12]. These records evince that vaccination coverage rates in Spain for the years 2021 and 2023 remained comparably stable. Notably, in 2024, a marginal augmentation in vaccination coverage for MMR and hexavalent vaccines was observed. This suggests a positive trend in the uptake of these essential vaccines, possibly due to public health campaigns and increasing public awareness of the benefits of vaccination. However, this positive trend was contrasted by a diminished coverage for influenza compared to the year 2021 [12]. Therefore, we believe the data on hesitancy and refusal of vaccination could be valuable in the current scenario of vaccination in Spain in 2024, as it highlights areas needing targeted interventions to improve vaccine uptake and address ongoing public concerns about vaccine safety and efficacy.

The SAGE Vaccine Hesitancy Working Group categorize vaccine hesitancy using a matrix of contextual influences, individual/social influences, and vaccine and vaccination specific issues [4, 17].

Our study delved into several contextual influences, particularly focusing on the sociodemographic and sociocultural characteristics of the population. Analysis of respondent age revealed higher rates of vaccine refusal among those over 60 years old. This does not coincide with previous findings from other studies, where a greater likelihood of vaccination was detected in older people because of increased health concerns and susceptibility to illness [11, 18,19,20,21]. We believe that the reason for this finding may stem from the significant rejection in our older population of the influenza vaccination, which is primarily targeted at people over 65 years old or with underlying pathologies in Spain, and from the difficulties already described in previous publications to achieve satisfactory vaccination coverage against influenza [21,22,23,24]. We also detected greater hesitancy among people under 30 years old, particularly due to concerns about diseases associated with vaccines and the cost of vaccines. This finding is consistent with previously published studies [11, 18,19,20,21, 25] and underscores the need for vaccination campaigns tailored to specific age groups, addressing their unique concerns and barriers.

When considering sex, our study revealed that women and parents with children under 15 years old, showed greater hesitancy due to the components of vaccines or diseases that have been associated with vaccines. Greater doubts were detected in women without children under 15 years old than in men. Moreover, women were more likely to refuse vaccines for their children, aligning with previous studies, which show a greater predisposition to vaccination in men than in women, and less acceptance and greater hesitancy in parents [11, 18, 26, 27]. Concretely, women with young children are more concerned about vaccinating their children, necessitating targeted strategies to bolster the trust and confidence, as previously proposed [11, 18, 27, 28].

Regarding education level, individuals without a university education exhibited greater hesitancy due to associated diseases or vaccine payment. This aligns with published studies that show that the higher the level of education, the greater the acceptance of vaccines [11, 18, 20, 23, 29].

Cultural, religious, and family beliefs emerged as influential factors associated with hesitancy and decision about vaccination, with a greater predisposition to get vaccinated if the sociocultural environment is provaccine. These results echo findings from prior studies [3, 10, 18].

It is essential to note that sociodemographic factors, do not act in isolation but interconnect with a range of contextual, individual, and vaccine-specific influences, as highlighted in the WHO 3 C model (confidence, complacency, and convenience) [4, 7, 17].

In terms of political and policy-related contextual influences, most respondents favoured free and compulsory vaccination, except those who refused vaccines or expressed hesitation because of components, associated diseases, or payment for vaccines. Although in recent years there has been growing traction for anti-vaccine movements, most of the population seems to be in favour of compulsory vaccination policies, as evidenced in a 2019 review. Moreover, it seems that support towards mandatory policies increases after their implementation [30]. Nonetheless, efforts to improve vaccine acceptance, such as enhancing education and providing proof of the efficacy, benefits and safety of vaccines, remain crucial [31].

We observed greater vaccine refusal and hesitancy among individuals who deemed health professionals or websites unreliable sources of vaccine information, while considering friends, family, or social networks as reliable sources. These results reinforce previous publications which stated that the crisis in the vaccination system and the resurgence of anti-vaccine movements are due to the increased accessibility of information and the reduced credibility of HCPs [5, 32]. Exposure to anti-vaccine content on social media was associated with refusal and hesitancy to vaccinate [33,34,35,36,37], highlighting the critical need to combat misinformation to mitigate its effects [35, 36].

Our study also suggests that a lack of trust in HCPs is associated with greater vaccine refusal and hesitancy. This aligns with existing reviews and published studies that conclude that vaccine safety and trust in health authorities are the main factors in promoting vaccine acceptance [11, 38]. According to the WHO’s “3Cs” model, confidence in vaccines and in the healthcare system constitute one of the three main determinants of vaccine hesitancy [4, 7, 17].

We detected a greater refusal of the vaccines for influenza, tetanus, papilloma, and varicella (chicken pox). Mostly individuals refused vaccines for themselves and, to a lesser extent, their children. These findings mirror other international studies which highlight the difficulties in achieving satisfactory vaccination coverage for influenza and papillomavirus [31, 36, 39]. Data published by the Spanish Ministry of Health also corroborate these difficulties in vaccination coverage for influenza, papilloma, and varicella in 2021–2022. In Spain, the recommendation to maintain vaccination coverage ≥ 95% for MMR vaccination in 2021–2022 was not achieved [12] and the goal of maintaining measles and rubella elimination status was not met [40]. Again, although there are high coverage rates for tetanus in primary vaccination with the hexavalent vaccine, vaccination coverage with Td decreases in adolescents [12]. In our study, we found a greater refusal of tetanus vaccine than the diphtheria vaccine, although tetanus and diphtheria vaccines are usually administered together. We attribute this difference and other similar ones to a possible lack of knowledge of the vaccination schedule in our reference population or to a greater popular knowledge of tetanus vaccine because of its indication for administration in certain wounds.

Our study revealed a relationship between having hesitancy due to vaccine components and refusing a vaccine. It also showed that having hesitancy due to vaccine components or associated diseases were associated with hesitancy due to vaccine payment. Earlier research has found that accessibility and cost, along with safety and efficacy were reasons for hesitancy [11, 17, 41]. In most Spanish autonomous communities, the Meningococcal ACWY and Meningococcal B vaccines are now part of the public vaccination schedule and thus should no longer be a reason for hesitancy because of costs in these cases [42].

Collective responsibility was assessed and greater refusal and hesitancy was detected in respondents who were unaware that individual vaccination protects the community. The concept of collective responsibility was one of five factors that affect people’s perception of vaccines, along with confidence (trust in vaccine efficacy and safety), complacency (perception about the risk of the disease), calculation (weighing the risks and benefits of vaccines) and constraint (accessibility of information about the vaccine). These are part of the 5Cs model [41], which extends from the 3 C model introduced by the WHO SAGE Working group [4].

We intended to study the profile of the local population with vaccine hesitancy and we observed heightened hesitancy among people who disagreed with cow’s milk consumption or the use of infant milk formulas, and those who adhered to a non-Mediterranean diet or favoured alternative or complementary treatments for healthcare. This profile of a population with a preference for natural therapies, skepticism towards established scientific positions, and greater reticence towards healthcare systems and HCPs, seems to be the profile of vaccine hesitancy detected in primary care. There is existing literature demonstrating that some individuals tend to reject vaccines due to a philosophy that values what is “natural” and perceives vaccines as toxic. These individuals often prefer alternative treatments, which they consider safer and more natural [43,44,45]. Additionally, some studies highlight a tendency in certain demographic groups to view cow’s milk as less natural, particularly in comparison to plant-based alternatives [46,47,48]. In another study published in the UK in the same year, rejection and hesitancy towards vaccination were also associated with low confidence in the health service [25]. To address vaccine hesitancy, we urge institutions and governmental bodies to seek strategies to enhance trust in HCPs, public health systems, authorities, and health policies. Encouraging shared participation in the formulation of vaccine recommendations is paramount [38]. Additionally, as previously suggested by some authors, novel approaches such as analysing population opinions on vaccination through social networks using artificial intelligence to complement traditional survey methods, can provide a more comprehensive understanding of vaccine refusal and hesitancy dynamics and allow targeted interventions. Such initiatives can facilitate effective engagement with diverse communities and foster informed decision-making regarding vaccination [34, 49,50,51,52].

One of the limitations of this study is the inherent recruitment bias associated with the online survey method, which restricted participation to individuals with internet access. This can produce selection bias problems because there are different probabilities of being involved in the study depending on where people live, their level of education, and their age. Therefore, this may hinder the generalization of the results. However, given that 96.1% of Spanish households have internet access and 85% of Spaniards are users of social networks [53, 54], the reach of our survey remains substantial. Another possible limitation is potential respondent repetition, although, we anticipate minimal impact on the final results because of expected low rate of repetition. Additionally, our sample skewed towards women and people with a university education, this could limit the interpretation and generalization of our study to the broader population. Additionally, the timing of the survey, conducted during the COVID-19 pandemic, may have influenced participants’ attitudes and perceptions due to heightened skepticism and rapidly evolving vaccination policies. However, vaccination coverage rates in Spain for the years 2021 and 2023 remained comparably stable, the insights into hesitancy and refusal may still be valuable for understanding the current vaccination scenario in Spain in 2024. The self-reported nature of the survey introduces the possibility of recall bias, particularly regarding vaccine refusal, as participants may not have accurately recalled all instances of refusal. Finally, reaching the anti-vaccine population posed challenges, as interactions with these groups is difficult. To mitigate eventual bias deriving from this, in our sample size calculation, we considered that the proportion of antivaccine responses would be much lower than the proportion of pro-vaccine responses. Despite these limitations, our study provides valuable insights into vaccine refusal and hesitancy, but caution is warranted in extrapolating findings to the entire population.

Conclusions

Vaccination refusal in our surveyed population was low and mainly related to refusal of influenza vaccination, although hesitancy arguments related to vaccine safety were detected, which could compromise vaccination coverage.

Vaccine refusal was mainly associated with individuals over 60 years old, characterized by hesitancy towards vaccine components, a resistance to compulsory vaccination, and a lack of awareness regarding vaccination’s community-wide protection benefits. Furthermore, resistance extended to dietary choices, notably being against cow’s milk and the use of infant formulas for breastfeeding.

Vaccine hesitancy, on the other hand, was mainly associated with a younger demographic of people under 30 years old, typically women, parents of young children under 15 years old, and against compulsory vaccination. They were generally also unaware that vaccination protects the community, with hesitancy about vaccine payment or with anti-vaccine attitudes, and in favour of alternative and complementary treatments.

In general, greater hesitancy to vaccination was detected in women and they reported a greater refusal to vaccinate their children than men.

Addressing these complexities requires proactive health policies aimed at strengthening trust in scientific positions and HCPs. Additionally, strategies must be tailored to enhance community engagement and ensure sufficient education regarding vaccination, especially among populations with lingering doubts. Multifaceted approaches are indispensable for navigating the intricacies of vaccine acceptance and safeguarding public health in the face of evolving challenges and threats to established progress made at reducing vaccine refusal and hesitancy.

Data availability

The data are hosted on the research team’s internal servers and will be provided under reasonable request.

Abbreviations

VPDs :

Vaccine preventable Diseases

SAGE:

Strategic Advisory Group of Experts

WHO:

World Health Organization

DTaP:

Diphtheria, Tetanus, Pertussis

MMR:

Measles, Mumps, and Rubella

HCPs:

Healthcare professionals

REDCap:

Research Electronic Data Capture

References

  1. OMS. Vacunas e inmunización: la seguridad de las vacunas. 2020 [accessed 2023-11-26]. Available from: https://www.who.int/es/news-room/questions-and-answers/item/vaccines-and-immunization-vaccine-safety

  2. Chen C, Yang Q, Tian H, Wu J, Chen L, Ji Z, et al. Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 2022. Hum Vaccin Immunother. 2023;19(2):2226584.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Swingle CA. How do we approach Anti-Vaccination attitudes?? Mo Med. 2018;115(3):180–1.

    PubMed  PubMed Central  Google Scholar 

  4. Meeting of the Strategic Advisory Group of Experts on immunization. October 2017 – conclusions and recommendations. Wkly Epidemiol Rec. 2017;92(48):729–47.

    Google Scholar 

  5. Hussain A, Ali S, Ahmed M, Hussain S. The Anti-vaccination movement: A regression in modern medicine. Cureus. 2018;10(7):e2919.

    PubMed  PubMed Central  Google Scholar 

  6. Tafuri S, Gallone MS, Cappelli MG, Martinelli D, Prato R, Germinario C. Addressing the anti-vaccination movement and the role of HCWs. Vaccine. 2014;32(38):4860–5.

    Article  CAS  PubMed  Google Scholar 

  7. MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.

    Article  PubMed  Google Scholar 

  8. OMS. Diez cuestiones de salud que la OMS abordará este año. 2019 [Accessed 20 May 2020]. Available from: https://www.who.int/es/news-room/spotlight/ten-threats-to-global-health-in-2019

  9. Ozawa S, Yemeke TT, Evans DR, Pallas SE, Wallace AS, Lee BY. Defining hard-to-reach populations for vaccination. Vaccine. 2019;37(37):5525–34.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hornsey MJ, Harris EA, Fielding KS. The psychological roots of anti-vaccination attitudes: A 24-nation investigation. Health Psychol. 2018;37(4):307–15.

    Article  PubMed  Google Scholar 

  11. Truong J, Bakshi S, Wasim A, Ahmad M, Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health Promot Int. 2022;37(1).

  12. Vacunas y Programa de Vacunación. Coberturas de Vacunación. Datos Estadísticos. Ministerio de Sanidad. Gobierno de España.2023 [accessed 2024-01-07]. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/calendario-y-coberturas/coberturas/home.htm

  13. Picchio CA, Carrasco MG, Sagué-Vilavella M, Rius C. Knowledge, attitudes and beliefs about vaccination in primary healthcare workers involved in the administration of systematic childhood vaccines, Barcelona, 2016/17. Euro Surveill. 2019;24(6).

  14. Caballero P, Astray J, Domínguez Á, Godoy P, Barrabeig I, Castilla J, et al. [Validation of the questionnaire on vaccines and hesitancy to be vaccinated in the Spanish society of epidemiology]. Gac Sanit. 2023;37:102329.

    Article  PubMed  Google Scholar 

  15. IDIAP JordiGol. REDCap. [accessed 2023-02-06]. Available from: https://redcap.link/uj4jozhy

  16. Huguet-Feixa A, Artigues-Barberà E, Sol J, Godoy P, Ortega Bravo M. Effects of the COVID-19 pandemic on the decision and doubts about vaccination in Catalonia: online Cross-sectional questionnaire. JMIR Form Res. 2023;7:e41799.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, et al. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165–75.

    Article  PubMed  Google Scholar 

  18. Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: A scoping review. Front Public Health. 2021;9:698111.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gagneux-Brunon A, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P, et al. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic Wave: a cross-sectional survey. J Hosp Infect. 2021;108:168–73.

    Article  CAS  PubMed  Google Scholar 

  20. Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–51.

    Article  CAS  PubMed  Google Scholar 

  21. Rönnerstrand B. Social capital and immunisation against the 2009 A(H1N1) pandemic in Sweden. Scand J Public Health. 2013;41(8):853–9.

    Article  PubMed  Google Scholar 

  22. Mesch GS, Schwirian KP. Social and political determinants of vaccine hesitancy: lessons learned from the H1N1 pandemic of 2009–2010. Am J Infect Control. 2015;43(11):1161–5.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Börjesson M, Enander A. Perceptions and sociodemographic factors influencing vaccination uptake and precautionary behaviours in response to the A/H1N1 influenza in Sweden. Scand J Public Health. 2014;42(2):215–22.

    Article  PubMed  Google Scholar 

  24. Ferrante G, Baldissera S, Moghadam PF, Carrozzi G, Trinito MO, Salmaso S. Surveillance of perceptions, knowledge, attitudes and behaviors of the Italian adult population (18–69 years) during the 2009–2010 A/H1N1 influenza pandemic. Eur J Epidemiol. 2011;26(3):211–9.

    Article  PubMed  Google Scholar 

  25. Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines (Basel). 2021;9(3).

  26. Damnjanović K, Graeber J, Ilić S, Lam WY, Lep Ž, Morales S, et al. Parental Decision-Making on childhood vaccination. Front Psychol. 2018;9:735.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative analysis of mothers’ decision-making about vaccines for infants: the importance of trust. Pediatrics. 2006;117(5):1532–41.

    Article  PubMed  Google Scholar 

  28. Hilton S, Smith E. Public views of the UK media and government reaction to the 2009 swine flu pandemic. BMC Public Health. 2010;10:697.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Myers LB, Goodwin R. Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health. 2011;11(1):15.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Seale H, Leask J, Macintyre CR. Awareness, attitudes and behavior of hospital healthcare workers towards a mandatory vaccination directive: two years on. Vaccine. 2011;29(21):3734–7.

    Article  PubMed  Google Scholar 

  31. Gualano MR, Olivero E, Voglino G, Corezzi M, Rossello P, Vicentini C, et al. Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Hum Vaccin Immunother. 2019;15(4):918–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Larson HJ, Schulz WS. Reverse global vaccine dissent. Science. 2019;364(6436):105.

    Article  CAS  PubMed  Google Scholar 

  33. Margolis MA, Brewer NT, Shah PD, Calo WA, Gilkey MB. Stories about HPV vaccine in social media, traditional media, and conversations. Prev Med. 2019;118:251–6.

    Article  PubMed  Google Scholar 

  34. Argyris YA, Monu K, Tan PN, Aarts C, Jiang F, Wiseley KA. Using machine learning to compare provaccine and antivaccine discourse among the public on social media: algorithm development study. JMIR Public Health Surveill. 2021;7(6):e23105.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Badur S, Ota M, Öztürk S, Adegbola R, Dutta A. Vaccine confidence: the keys to restoring trust. Hum Vaccin Immunother. 2020;16(5):1007–17.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dunn AG, Surian D, Leask J, Dey A, Mandl KD, Coiera E. Mapping information exposure on social media to explain differences in HPV vaccine coverage in the united States. Vaccine. 2017;35(23):3033–40.

    Article  PubMed  Google Scholar 

  37. Burki T. The online anti-vaccine movement in the age of COVID-19. Lancet Digit Health. 2020;2(10):e504–5.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34(52):6700–6.

    Article  PubMed  Google Scholar 

  39. Ahmed N, Quinn SC, Hancock GR, Freimuth VS, Jamison A. Social media use and influenza vaccine uptake among white and African American adults. Vaccine. 2018;36(49):7556–61.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Plan estratégico para la eliminación del sarampión y. la rubeola en España 2021–2025: Ministerio de Sanidad. Gobierno de España; 2021 [accessed 2024-01-19]. Available from: www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/sarampion-rubeola/docs/PlanEstrategico_SarampionyRubeola.pdf

  41. Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: development of a measure assessing the 5 C psychological antecedents of vaccination. PLoS ONE. 2018;13(12):e0208601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Vacunas y Programa de Vacunación. Calendarios de vacunación en las Comunidades Autónomas.: Ministerio de Sanidad. Gobierno de España.; 2023 [accessed 2023-01-07]. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario-y-coberturas/calendario/Calendario_CCAA.htm

  43. Filice E, Dubé E, Graham JE, MacDonald NE, Bettinger JA, Greyson D, et al. Vaccination discourses among chiropractors, naturopaths and homeopaths: A qualitative content analysis of academic literature and Canadian organizational webpages. PLoS ONE. 2020;15(8):e0236691.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Attwell K, Leask J, Meyer SB, Rokkas P, Ward P. Vaccine rejecting parents’ engagement with expert systems that inform vaccination programs. J Bioeth Inq. 2017;14(1):65–76.

    Article  PubMed  Google Scholar 

  45. Busse JW, Walji R, Wilson K. Parents’ experiences discussing pediatric vaccination with healthcare providers: a survey of Canadian naturopathic patients. PLoS ONE. 2011;6(8):e22737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Jeske S, Zannini E, Arendt EK. Evaluation of physicochemical and glycaemic properties of commercial Plant-Based milk substitutes. Plant Foods Hum Nutr. 2017;72(1):26–33.

    Article  CAS  PubMed  Google Scholar 

  47. Antunes IC, Bexiga R, Pinto C, Roseiro LC, Quaresma MAG. Cow’s Milk in Human Nutrition and the Emergence of Plant-Based Milk Alternatives. Foods. 2022;12(1).

  48. Dubé E, Vivion M, Sauvageau C, Gagneur A, Gagnon R, Guay M. How do midwives and physicians discuss childhood vaccination with parents?? J Clin Med. 2013;2(4):242–59.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Hussain A, Tahir A, Hussain Z, Sheikh Z, Gogate M, Dashtipour K, et al. Artificial Intelligence-Enabled analysis of public attitudes on Facebook and Twitter toward COVID-19 vaccines in the united Kingdom and the united States: observational study. J Med Internet Res. 2021;23(4):e26627.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kwok SWH, Vadde SK, Wang G. Tweet topics and sentiments relating to COVID-19 vaccination among Australian Twitter users: machine learning analysis. J Med Internet Res. 2021;23(5):e26953.

    Article  PubMed  PubMed Central  Google Scholar 

  51. To QG, To KG, Huynh VN, Nguyen NT, Ngo DT, Alley S, et al. Anti-vaccination attitude trends during the COVID-19 pandemic: A machine learning-based analysis of tweets. Digit Health. 2023;9:20552076231158033.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ahmed W, Vidal-Alaball J, Vilaseca JM. A social network analysis of Twitter data related to blood clots and vaccines. Int J Environ Res Public Health. 2022;19(8).

  53. Idescat. Llars amb accés a Internet: Institut d’Estadística de Catalunya; 2022 [Accessed 28 Nov 2023]. Available from: https://www.idescat.cat/indicadors/?id=ue&n=10144

  54. Statista. Penetración de las redes sociales en España de 2010 a 2023 2023 [Accessed 28 Nov 2023]. Available from: https://es.statista.com/estadisticas/910163/redes-sociales-porcentaje-de-usuarios-por-comunidad-autonoma-en-espana/

Download references

Acknowledgements

Data collection would not have been possible without the collaboration of the MC- MUVA work group, the Xarxa de Recerca en Pediatria d’Atenció Primària [Research Network of Primary Care Paediatrics], and the Societat Catalana de Pediatria [Catalan Society of Paediatrics]. Our special thanks go to the dedicated investigators and participants. MC-MUVA work group: Rebecca Oglesby, Merce Font Arbó, Lidia Sanz Borrell, Mireia Biosca Pàmies, Marta Pifarre Ortiz, Sara Martí Martí, Daniel Gros Esteban, Laura Guix Cliville, Noelia Diaz Charles, Silvia Prado Muñoz, Susana Perez Osuna, Mercè Giribet Folch, Magda Riera Veciana, Carles Gatius Tonda, Laura Seoane Barbosa, Pilar Serra Solans, Míriam Poblet, M. José Castañ Castillo, Elena Alcover Bloch, Anna Castan, Magda Barberà Farré, Sara Serra Font, Mònica Martinez, Imma Caubet Busquet, Maria Planella Cornudella, Gema Terrer Manrique, Raul Morales, Anna Gatell Carbo, Carme Farran Balcells, Carmen Gómez Seara, Viktoriya Atroshchenko Shushko, Margaret Creus Verni, Veronida Mª Karcz, Judith Palacin Aguilà, Joana Garcia Hinojosa, Mihaela Cozar, Rosa Aran Padullés, Ramón Capdevila Bert, Montse Crespo Pons, Maria Jose Lara Tostado, Isabel Segarra Solanes, Enmanuel Aneudi Estevez Genao, Raquel Plasencia Atienza, Maria Chiné Segura, Meritxell Pelegrí Romeo, Montse Farran Jové, Carme Trilla Felis, Rubén Lopez Ruiz, Iratxe Olabegoya Estrela, Roser Racero Maire, Sonia Asensio, Merce Lozano Vergara, Mercè Cortés Lladó, Àngels Font Anglada, Sara Borrat Padrosa, Maria Payan Sala, Bárbara Montilla Cabrera, Samanta Barisonzi Zambrano, Almudena Sanchez, Cristina Casademont, Pyrene Martinez, Anna M. Ristol Perxés, Irene Gómez i Pérez, Jaume Miquel Salsas.

Funding

This work was supported by Ajuts a Projectes en Projectes en Recerca en Atenció Primària-Diputació Lleida 2021-1a Edició (Ajut PICARD) modalitat projecte (4R22/152) y modalitat publicació i traducció d’articles (9F22/017) and by BECA AEPap-FPS 2020 for research in Primary Care Paediatrics.

Author information

Authors and Affiliations

Authors

Contributions

AH-F, EA-B, MOB contributed to the study concept and research design, selected, and reviewed the literature on vaccination. JS and XG-A participated in the acquisition, analysis, and interpretation of data. AH-F, EA-B, MOB, JS, XG-A and PG participated in the writing and critical review of the manuscript and approved the final version. AH-F and Group MC-MUVA contributed to the recruitment.

Corresponding authors

Correspondence to Eva Artigues-Barberà or Marta Ortega Bravo.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics and Clinical Research Committee of the Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), with code 20/221-P. The study was conducted following the principles of the Declaration of Helsinki.

Informed consent was obtained from all the subjects involved in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huguet-Feixa, A., Artigues-Barberà, E., Sol, J. et al. Vaccine refusal and hesitancy in Spain: an online cross-sectional questionnaire. BMC Prim. Care 26, 132 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12875-025-02820-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12875-025-02820-2

Keywords